Thus, the down-regulation of Sef expression favors the creation of an inflammatory tumor microenvironment, characterized by a higher colitis score, increased immune cell infiltration and an increase in circulating pro-inflammatory cytokines, conducive to tumor development. The gene discussed is IL17RD; the disease is neoplasm.